Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
Background: Gaps in current evidence and guidance leave clinicians with unanswered questions on the use of cladribine tablets for the treatment of multiple sclerosis (MS) in the era of the COVID-19 pandemic, in particular relating to COVID-19 vaccination. Objective: We describe a consensus-based pro...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2021-12-01
|
| Schriftenreihe: | Therapeutic Advances in Neurological Disorders |
| Online-Zugang: | https://doi.org/10.1177/17562864211058298 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|